MedWatch Safety Alerts

0.9 Percent Sodium Chloride Injection, USP, 250 mL by Hospira : Recall - Particulate Matter

Injected particulate material may result in local inflammation, phlebitis, and/or low-level allergic response.

Learn More

Bone Graft Substitutes Containing Recombinant Proteins or Synthetic Peptides in Patients Under Age 18: FDA Safety Communication - Reports of Serious Injuries

Risk of excess bone growth, fluid accumulation, inhibited bone healing, and swelling.

Learn More

Simulated IV Solutions from Wallcur: CDER Statement- FDA's Investigation into Patients being Injected

FDA and the CDC continue to investigate multiple instances of simulated saline solution being administered to patients and to alert health care providers and regulatory officials to raise awareness of the potential risk. Originally Posted 1/14/2015

Learn More

IV Solutions from Wallcur of San Diego: CDER Statement - FDA Warns Health Care Professionals Not to Inject Patients

UPDATED 01/10/2015 Wallcur Practi-IV solutions bags are recalled.

Learn More

Prescription and Over-the-Counter (OTC) Pain Medicines: Drug Safety Communication - FDA Review of Possible Risks of Pain Medicine Use During Pregnancy

Pregnant women urged to discuss all medicines with their health care professionals before using them.

Learn More

Virazole (Ribavirin Powder For Solution) by Valeant Pharmaceutical North America, LLC: Recall- Due to Microbial Contamination

Inhalation of a non-sterile product with microbial contamination into the airways could increase the risk of respiratory infection.

Learn More

KimVent Microcuff Subglottic Suctioning Endotracheal Tubes by Halyard Health: Class I Recall - Component May Detach During Use

An air leak between cuff and tracheal wall may reduce the amount of air that reaches the lungs. Use of this recalled product could cause serious health risks, including delayed patient treatment, breathing difficulties, and death.

Learn More

Call us toll-free at (800) 641-0098